High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders.
作者信息
Jolles S
出版信息
Clin Exp Immunol. 2002 Sep;129(3):385-9. doi: 10.1046/j.1365-2249.2002.01967.x.
Abstract
摘要
相似文献
1
High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders.大剂量静脉注射免疫球蛋白（hdIVIg）治疗自身免疫性水疱病
Clin Exp Immunol. 2002 Sep;129(3):385-9. doi: 10.1046/j.1365-2249.2002.01967.x.
2
High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases.大剂量静脉注射免疫球蛋白治疗自身免疫性黏膜皮肤水疱病：19例应用评估
J Am Acad Dermatol. 2007 Jun;56(6):960-7. doi: 10.1016/j.jaad.2006.06.029. Epub 2007 Mar 21.
3
Dermatological uses of high-dose intravenous immunoglobulin.大剂量静脉注射免疫球蛋白的皮肤科应用。
Arch Dermatol. 1998 Jan;134(1):80-6. doi: 10.1001/archderm.134.1.80.
4
Treatment Update of Autoimmune Blistering Diseases.自身免疫性水疱病的治疗进展
Dermatol Clin. 2019 Apr;37(2):215-228. doi: 10.1016/j.det.2018.12.003. Epub 2019 Feb 14.
5
Autoimmune bullous diseases: diagnosis and management.自身免疫性大疱性疾病：诊断与管理
Dermatol Nurs. 2006 Feb;18(1):20-5.
6
A review of high-dose intravenous immunoglobulin (hdIVIg) in the treatment of the autoimmune blistering disorders.大剂量静脉注射免疫球蛋白（hdIVIg）治疗自身免疫性水疱病的综述。
Clin Exp Dermatol. 2001 Mar;26(2):127-31. doi: 10.1046/j.1365-2230.2001.00779.x.
7
High-dose intravenous immune globulin for the treatment of autoimmune blistering diseases: an evaluation of its use in 14 cases.大剂量静脉注射免疫球蛋白治疗自身免疫性水疱病：14例应用评估
Br J Dermatol. 1999 May;140(5):865-74. doi: 10.1046/j.1365-2133.1999.02817.x.
8
Mucocutaneous features of autoimmune blistering diseases.自身免疫性水疱病的黏膜皮肤特征。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Nov;84(5):517-34. doi: 10.1016/s1079-2104(97)90269-9.
9
A systematic review on efficacy, safety and treatment durability of intravenous immunoglobulin in autoimmune bullous dermatoses: Special focus on indication and combination therapy.一项关于静脉注射免疫球蛋白治疗自身免疫性大疱性皮肤病的疗效、安全性和治疗持久性的系统评价：特别关注适应证和联合治疗。
Exp Dermatol. 2023 Jul;32(7):934-944. doi: 10.1111/exd.14829. Epub 2023 May 7.
10
New immunomodulating drugs in autoimmune blistering diseases.自身免疫性水疱病中的新型免疫调节药物。
Dermatol Clin. 2001 Oct;19(4):637-48, viii. doi: 10.1016/s0733-8635(05)70305-3.
引用本文的文献
1
Intravenous Immunoglobulin: Revisited - My Experience.静脉注射免疫球蛋白：再探讨——我的经历
Indian J Dermatol. 2021 May-Jun;66(3):329. doi: 10.4103/ijd.IJD_559_17.
2
Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model FcγRIIA and FcαRI.免疫调节：免疫球蛋白制剂在新冠病毒疾病模型中抑制过度炎症反应 FcγRIIA 和 FcαRI。
Front Immunol. 2021 Jun 10;12:700429. doi: 10.3389/fimmu.2021.700429. eCollection 2021.
3
Biologics in dermatology: an integrated review.皮肤科生物制剂：综合综述。
Indian J Dermatol. 2014 Sep;59(5):425-41. doi: 10.4103/0019-5154.139859.
4
The role of intravenous immunoglobulin preparations in the treatment of systemic sclerosis.静脉注射免疫球蛋白制剂在系统性硬化症治疗中的作用。
Int J Rheumatol. 2011;2011:829751. doi: 10.1155/2011/829751. Epub 2011 Nov 2.
5
High-dose intravenous immunoglobulin (IVIG) therapy in autoimmune skin blistering diseases.大剂量静脉注射免疫球蛋白（IVIG）治疗自身免疫性皮肤水疱病。
Clin Rev Allergy Immunol. 2010 Apr;38(2-3):186-95. doi: 10.1007/s12016-009-8153-y.
6
Intravenous immunoglobulin: an update on the clinical use and mechanisms of action.静脉注射免疫球蛋白：临床应用及作用机制的最新进展
J Clin Immunol. 2007 May;27(3):233-45. doi: 10.1007/s10875-007-9088-9. Epub 2007 Mar 11.
7
Preliminary data on Pemphigus vulgaris treatment by a proteomics-defined peptide: a case report.蛋白质组学定义的肽治疗寻常型天疱疮的初步数据：病例报告。
J Transl Med. 2006 Oct 24;4:43. doi: 10.1186/1479-5876-4-43.
8
Clinical uses of intravenous immunoglobulin.静脉注射免疫球蛋白的临床应用。
Clin Exp Immunol. 2005 Oct;142(1):1-11. doi: 10.1111/j.1365-2249.2005.02834.x.
9
Autoimmune bullous diseases: ocular manifestations and management.自身免疫性大疱性疾病：眼部表现与治疗
Drugs. 2005;65(13):1767-79. doi: 10.2165/00003495-200565130-00003.
本文引用的文献
1
Immunomodulatory action of intravenous immunoglobulin.静脉注射免疫球蛋白的免疫调节作用。
Immunology. 2002 Dec;107(4):387-93. doi: 10.1046/j.1365-2567.2002.01545.x.
2
Treatment of oral pemphigoid with intravenous immunoglobulin as monotherapy. Long-term follow-up: influence of treatment on antibody titres to human alpha6 integrin.静脉注射免疫球蛋白单药治疗口腔类天疱疮。长期随访：治疗对人α6整合素抗体滴度的影响。
Clin Exp Immunol. 2002 Sep;129(3):533-40. doi: 10.1046/j.1365-2249.2002.01942.x.
3
Steroid sparing effect of intravenous immunoglobulin therapy in patients with pemphigus foliaceus.静脉注射免疫球蛋白疗法对落叶型天疱疮患者的激素节省作用。
Eur J Dermatol. 2002 Mar-Apr;12(2):174-8.
4
Intravenous immunoglobulin therapy in patients with multiple mucosal involvement in mucous membrane pemphigoid.静脉注射免疫球蛋白治疗黏膜类天疱疮多黏膜受累患者。
Clin Immunol. 2002 Jan;102(1):59-67. doi: 10.1006/clim.2001.5150.
5
Cicatricial pemphigoid with circulating IgA and IgG autoantibodies to the central portion of the BP180 ectodomain: beneficial effect of adjuvant therapy with high-dose intravenous immunoglobulin.伴有循环性抗BP180胞外域中央部分IgA和IgG自身抗体的瘢痕性类天疱疮：大剂量静脉注射免疫球蛋白辅助治疗的有益效果
J Am Acad Dermatol. 2002 Jan;46(1):116-22. doi: 10.1067/mjd.2002.117860.
6
Intravenous immunoglobulin therapy for patients with pemphigus foliaceus unresponsive to conventional therapy.静脉注射免疫球蛋白治疗对传统治疗无反应的落叶型天疱疮患者。
J Am Acad Dermatol. 2002 Jan;46(1):42-9. doi: 10.1067/mjd.2002.116338.
7
Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment.静脉注射免疫球蛋白疗法治疗对传统免疫抑制治疗无反应的寻常型天疱疮患者。
J Am Acad Dermatol. 2001 Nov;45(5):679-90. doi: 10.1067/mjd.2001.116339.
8
Comparison between intravenous immunoglobulin and conventional immunosuppressive therapy regimens in patients with severe oral pemphigoid: effects on disease progression in patients nonresponsive to dapsone therapy.重度类天疱疮患者静脉注射免疫球蛋白与传统免疫抑制治疗方案的比较：对氨苯砜治疗无反应患者疾病进展的影响
Arch Dermatol. 2001 Sep;137(9):1181-9. doi: 10.1001/archderm.137.9.1181.
9
Diagnostic features of pemphigus vulgaris in patients with pemphigus foliaceus: detection of both autoantibodies, long-term follow-up and treatment responses.落叶型天疱疮患者中寻常型天疱疮的诊断特征：两种自身抗体的检测、长期随访及治疗反应
Clin Exp Immunol. 2001 Sep;125(3):492-8. doi: 10.1046/j.1365-2249.2001.01637.x.
10
Linear IgA bullous disease limited to the eye: a diagnostic dilemma: response to intravenous immunoglobulin therapy.局限于眼部的线状IgA大疱性疾病：诊断难题：对静脉注射免疫球蛋白治疗的反应
Ophthalmology. 2000 Aug;107(8):1524-8. doi: 10.1016/s0161-6420(00)00245-1.
Zotero 插件